2007
DOI: 10.1016/j.pec.2007.06.015
|View full text |Cite
|
Sign up to set email alerts
|

Disrupted social connectedness among Dominican women with chronic filarial lymphedema

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
33
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 32 publications
(34 citation statements)
references
References 39 publications
(43 reference statements)
1
33
0
Order By: Relevance
“…In this study, an association was found between stigma and factors including monthly income, marital status, and disease stage after controlling for confounders. Similarly, disease stage was found to be associated with stigma among LF patients in other studies [29,35]. This may be because increased podoconiosis disease stage is more visible than lower stages.…”
Section: Discussionsupporting
confidence: 59%
See 3 more Smart Citations
“…In this study, an association was found between stigma and factors including monthly income, marital status, and disease stage after controlling for confounders. Similarly, disease stage was found to be associated with stigma among LF patients in other studies [29,35]. This may be because increased podoconiosis disease stage is more visible than lower stages.…”
Section: Discussionsupporting
confidence: 59%
“…Age and social role appeared to influence social connectedness among LF patients in a study by Person et al . [29]. In the same study, stigma appeared to be correlated with increasing disease stage [29].…”
Section: Introductionmentioning
confidence: 90%
See 2 more Smart Citations
“…4 Affected individuals often suffer impairment of daily activities and social isolation in addition to the pain and discomfort of severe disease. 5 The Dominican Ministry of Health created the Program to Eliminate Lymphatic Filariasis (PELF) in 1998 to coordinate national LF elimination. Patterned after the global strategy, PELF targets elimination of LF through 1) annual mass drug administration (MDA) of albendazole (donated by GlaxoSmithKline) and diethylcarbamazine (DEC) to interrupt LF transmission by 2020; and 2) morbidity control to alleviate disability for those already infected.…”
mentioning
confidence: 99%